Focus Partners Wealth
OMGA

Focus Partners Wealth’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Focus Partners Wealth’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,000
Closed -$10.4K – 2059
2024
Q4 		$10.4K Buy
+14,000
New +$13.9K ﹤0.01% 1863
2024
Q3 		– Sell
-13,000
Closed -$27K – 1731
2024
Q2 		$27K Buy
13,000
+3,000
+30% +$7.07K ﹤0.01% 1215
2024
Q1 		$25K Buy
+10,000
New +$38.3K ﹤0.01% 975

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Focus Partners Wealth's OMGA Position: Q1 2025 in Review

Focus Partners Wealth sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 14,000 shares — an estimated $10.4K sold.

Focus Partners Wealth first reported a position in OMGA in Q1 2024 and held it in 3 quarters. The position peaked at $27K in Q2 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Focus Partners Wealth reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Focus Partners Wealth sold 14,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $10.4K.
  • Focus Partners Wealth first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Focus Partners Wealth's Omega Therapeutics, Inc. Common Stock position peaked at $27K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Focus Partners Wealth's 13F filing for Q1 2025, filed 15 May 2025.